Cargando…
PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data
PIK3CA mutations represent one of the most common genetic aberrations in breast cancer. They have been reported to be present in over one-third of cases, with enrichment in the luminal and in human epidermal growth factor receptor 2-positive subtypes. Substantial preclinical data on the oncogenic pr...
Autores principales: | Zardavas, Dimitrios, Phillips, Wayne A, Loi, Sherene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4054885/ https://www.ncbi.nlm.nih.gov/pubmed/25192370 http://dx.doi.org/10.1186/bcr3605 |
Ejemplares similares
-
PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer
por: Loi, Sherene, et al.
Publicado: (2013) -
Correction: PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer
por: Loi, Sherene, et al.
Publicado: (2019) -
Mouse Models for Exploring the Biological Consequences and Clinical Significance of PIK3CA Mutations
por: Mitchell, Camilla B., et al.
Publicado: (2019) -
PIK3CA-mutations in breast cancer
por: Reinhardt, Kristin, et al.
Publicado: (2022) -
Initiating breast cancer by PIK3CA mutation
por: Miller, Todd W
Publicado: (2012)